1 romosome 9p21, an area frequently deleted in bladder neoplasms.

2 ise the clinical management of patients with bladder neoplasms.

3 RT promoter in a separate series of 14 early bladder neoplasms and matched follow-up urine samples to

4 lecular events underlying different types of bladder neoplasms, and can serve as useful preclinical m

5 f both p53 and pRB proteins in patients with bladder neoplasms compared with having one or neither ab

6 ological and radiological characteristics of bladder neoplasms, describes bladder MRI, explains the V

7 f this CpG island in 20 of 47 cases (43%) of bladder neoplasms ranging from low-grade papillary neopl

8 ll transgenic mice developed highly invasive bladder neoplasms that resembled invasive human bladder

9 enty-six patients suspected or known to have bladder neoplasms underwent CT virtual and conventional